Pairwise pathway impact analysiswas performed for different subgroups, CL3 vs RL3, CL3 vs RL3U, andCL3 vs RL3B, to identify the pathways being affected in unilateraland bilateral Rb patients (Figure 7). The gene discussed is ADGRL3; the disease is retinoblastoma.